Brainstorm Cell Therapeutics Inc.

(BCLI) Trade

By |

Profile

Brainstorm Cell Therapeutics Inc is a biotechnology company. The Company develops novel adult stem cell therapies for debilitating neurodegenerative disorders such as ALS, MS, and PD among others.

Contact Information

Website: www.brainstorm-cell.com
Email: mrice@lifesciadvisors.com
Main Phone: +1 201 488-0460
Address: 1745 Broadway
Address 2: 17th Floor
State: NJ
City / Town: Hackensack
Country: USA
Postal Code: 07601

Issuer Information

Exchange: NSC
CEO: Chaim Lebovits
Employees: 29
NAICS: Pharmaceutical Preparation Manufacturing(325412)
$ 3.89 $ -0.04 (-1.02%)
Last Price 3.89 Change $ -0.04 Change % -1.02 Tick N/A
Bid 3.88 Bid Size 2,500.00 Ask 3.90 Ask Size 700.00
Open 3.92 High 3.96 Low 3.87 Prev Close 3.93
Last Trade Volume 41,346 52 Wk Hi 5.35 52 Wk Low 2.88
Market Cap 80.4 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 20,669,528.00 EPS (TTM) -0.39 PE Ratio N/A Exchange NCM
  Last 3 Mo Last 12 Mo
Number of Insider Trades 1 15
Number of Buys 1 15
Number of Sells 0 0
Net Activity 1249 130203
Last 10 Buys Shares
June Almenoff 1,000
Ralph Kern 1,000
Irit Arbel 1,000
Uri Yablonka 1,000
Yoram Bibring 1,000
Yoram Bibring 1,000
Anthony Fiorino 1,000
Anthony Fiorino 1,000
Last 10 Sell Shares
Robert G.L. Shorr 1,000
Malcolm S. Taub 1,000
Mordechai Friedman 1,000
Malcolm S. Taub 1,000
Robert G.L. Shorr 1,000
Malcolm S. Taub 1,000
Robert G.L. Shorr 1,000
Malcolm S. Taub 1,000
Robert G.L. Shorr 1,000
Robert G.L. Shorr 1,000
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 15 15 15 15
Low Target Price Estimate 9 9 9 9
Mean Target Price Estimate 11.67 11.67 11.67 11.67
Standard Deviation 3.06 3.06 3.06 3.06
Date of Most Recent Estimate 05/17/18 05/17/18 05/17/18 06/11/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 2 2 1 1
Moderate Buy 0 0 0 0
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1 1 1 1